No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
5-probe cocktail |
- |
- |
- |
- |
1件: 254 |
2 |
Afamelanotide |
Afamelanotide |
D10511 |
- |
- |
1件: 254 |
3 |
Aln-60519 |
- |
- |
- |
- |
1件: 254 |
4 |
Aln-as1 |
- |
- |
- |
- |
1件: 254 |
5 |
Cas # in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
1件: 254 |
6 |
Cas# in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
1件: 254 |
7 |
Chlorpromazine |
Chlorpromazine |
D00270, D00789, D03274, D04034 |
13件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C |
20件: Alcoholism, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
1件: 254 |
8 |
Chlorpromazine hydrochloride |
Chlorpromazine |
D00270, D00789, D03274, D04034 |
13件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C |
20件: Alcoholism, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
1件: 254 |
9 |
Colestipol |
Colestipol |
D02113, D07771 |
- |
- |
1件: 254 |
10 |
Colestyramine |
Cholestyramine |
- |
- |
- |
1件: 254 |
11 |
Cuv1647 |
- |
- |
- |
- |
1件: 254 |
12 |
Cysteine |
L-cysteine |
D00026, D02326 |
- |
- |
9件: 6, 13, 19, 84, 85, 88, 90, 254, 296 |
13 |
Cysteine hydrochloride |
L-cysteine |
D00026, D02326 |
- |
- |
1件: 254 |
14 |
Deferasirox |
Deferasirox |
D03669 |
- |
- |
3件: 254, 284, 286 |
15 |
Exjade |
Deferasirox |
D03669 |
- |
- |
3件: 254, 284, 286 |
16 |
Givosiran |
Givosiran |
- |
- |
- |
1件: 254 |
17 |
Givosiran (aln-as1) |
Givosiran |
- |
- |
- |
1件: 254 |
18 |
Harvoni |
Sofosbuvir |
D10366 |
- |
- |
1件: 254 |
19 |
Heme arginate |
- |
- |
- |
- |
1件: 254 |
20 |
Hemin |
Hemin |
D10003 |
2件: ALAS1, ALAS2 |
3件: Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
1件: 254 |
21 |
Hemin for injection |
Hemin |
D10003 |
2件: ALAS1, ALAS2 |
3件: Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
1件: 254 |
22 |
Hydroxychloroquine |
Hydroxychloroquine |
D08050 |
- |
- |
18件: 13, 41, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 222, 234, 254, 271, 298, 299 |
23 |
Iron |
Iron |
- |
- |
- |
7件: 13, 62, 86, 96, 97, 254, 284 |
24 |
Isoniazid |
Isoniazid |
D00346, D01501, D02002 |
- |
- |
1件: 254 |
25 |
Luteinizing hormone |
Luteinizing hormone |
- |
- |
- |
1件: 254 |
26 |
Luteinizing hormone-releasing factor |
Luteinizing hormone |
- |
- |
- |
1件: 254 |
27 |
Mt-7117 high dose |
- |
- |
- |
- |
1件: 254 |
28 |
Mt-7117 low dose |
- |
- |
- |
- |
1件: 254 |
29 |
Oral iron |
Iron |
- |
- |
- |
1件: 254 |
30 |
Panhematin |
Hemin |
D10003 |
2件: ALAS1, ALAS2 |
3件: Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
1件: 254 |
31 |
Porphobilinogen |
Porphobilinogen |
- |
- |
- |
1件: 254 |
32 |
Questran |
Cholestyramine |
- |
- |
- |
3件: 93, 254, 297 |
33 |
Recombinant human porphobilinogen deaminase (porphozym) |
Porphobilinogen |
- |
- |
- |
1件: 254 |
34 |
Sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
3件: 62, 234, 254 |
35 |
Tin mesoporphyrin |
Stannsoporfin |
D05922 |
2件: HMOX1, HMOX2 |
9件: Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin and chlorophyll metabolism |
1件: 254 |